Domov › Zelené karty › Takeda Pharmaceuticals USA, Inc.
Takeda Pharmaceuticals USA, Inc.: sponzoring zelenej karty (PERM)
Takeda Pharmaceuticals USA, Inc. podal 25 žiadostí o certifikáciu práce PERM rozhodnutých vo fiškálnych rokoch 2024–2026; certifikovaných: 21. Medián ponúkaného platu $151 000; mediánová doba od podania po certifikáciu: 479 dní.
Žiadosti PERM25
Certifikované21
Medián ponúkaného platu$151 000
Medián dní do certifikácie479
Už pracuje pre zamestnávateľa100 %
Zamestnanci (podľa podania)1 497
Na trhu od roku1998
Adresa zamestnávateľaLexington, MA
Platy H-1B v Takeda Pharmaceuticals USA, Inc. →
Pracovné pozície
| Pracovná pozícia | Žiadosti PERM | Mediánová mzda |
|---|---|---|
| Manager, GI Rare Data Analytics | 1 | $140 500 |
| Associate Director - Strategic Procurement Manager | 1 | $143 500 |
| Platform Architect | 1 | $140 500 |
| Patient Insights & Analytics Lead | 1 | $130 200 |
| Senior Analyst, Data Insights & Analytics | 1 | $98 900 |
| Senior Counsel, Data, Technology & Innovation | 1 | $258 523 |
| Quality Control Manager | 1 | $176 000 |
| Director Global Oncology Forecasting | 1 | $240 200 |
| Director/Global Category Manager for Cell Therapies | 1 | $239 200 |
| Product Manager, R&D Development Technology | 1 | $209 200 |
| People Analytics Consultant | 1 | $130 200 |
| Product Manager - Knowledge Graph and Advanced Analytics | 1 | $136 200 |
| Senior Analyst, Decision & Predictive Analytics | 1 | $81 900 |
| Global Health Economics Lead | 1 | $165 200 |
| Business Domain Technical Architect | 1 | — |
| Director, Strategy and Operations Lead - Omni-channel Engage | 1 | — |
| DevOps Platform Engineer | 1 | $151 000 |
| Head of Global Pricing and Access Platforms & Service Line | 1 | $158 100 |
| Scrum Master | 1 | $132 500 |
| Head of Platform Delivery | 1 | $224 100 |
| Data Platform Engineer - GMSGQ | 1 | $177 341 |
| Associate Scientific Director | 1 | — |
| Senior IS/IT Analyst, Product Manager – Vaccines Discovery a | 1 | $105 000 |
| Global New Product Lead, Neuroscience | 1 | — |
| IT Business Strategy & Process Lead - Mgr | 1 | $156 200 |
Miesta výkonu práce
Povolania
- Operations Research Analysts3
- Data Scientists2
- Computer Systems Analysts2
- Natural Sciences Managers2
- Computer and Information Systems Managers2
- Supply Chain Managers1
- Statisticians1
- Lawyers1
- Industrial Production Managers1
- Bioengineers and Biomedical Engineers1
Najnovšie rozhodnutia
| Pracovná pozícia | Základná mzda | Lokalita | Podané | Rozhodnuté | Stav | Dni |
|---|---|---|---|---|---|---|
| Data Platform Engineer - GMSGQ | $177 341–$228 000 | Cambridge, MA | 19. 5. 2025 | 26. 6. 2026 | Certifikované | 403 |
| Head of Platform Delivery | $224 100–$275 600 | Cambridge, MA | 12. 5. 2025 | 16. 6. 2026 | Certifikované | 400 |
| Scrum Master | $132 500–$186 000 | Cambridge, MA | 26. 3. 2025 | 22. 5. 2026 | Certifikované | 422 |
| Head of Global Pricing and Access Platforms & Service Line | $158 100–$255 600 | Cambridge, MA | 4. 11. 2024 | 16. 4. 2026 | Certifikované | 528 |
| DevOps Platform Engineer | $151 000–$180 000 | Lexington, MA | 8. 2. 2024 | 10. 11. 2025 | Certifikované, expirované | 641 |
| People Analytics Consultant | $130 200–$223 200 | Lexington, MA | 2. 6. 2024 | 5. 9. 2025 | Certifikované | 460 |
| Product Manager, R&D Development Technology | $209 200–$223 200 | Cambridge, MA | 18. 4. 2024 | 6. 8. 2025 | Certifikované | 475 |
| Director/Global Category Manager for Cell Therapies | $239 200–$283 200 | Cambridge, MA | 12. 4. 2024 | 4. 8. 2025 | Certifikované | 479 |
| Director Global Oncology Forecasting | $240 200–$283 200 | Cambridge, MA | 24. 4. 2024 | 1. 8. 2025 | Certifikované | 464 |
| Quality Control Manager | $176 000–$205 000 | Lexington, MA | 25. 3. 2024 | 17. 7. 2025 | Certifikované | 479 |
| Senior Counsel, Data, Technology & Innovation | $258 523–$362 000 | Lexington, MA | 17. 3. 2024 | 17. 7. 2025 | Certifikované | 487 |
| Senior Analyst, Data Insights & Analytics | $98 900–$140 400 | Cambridge, MA | 5. 3. 2024 | 17. 7. 2025 | Certifikované | 499 |
| Patient Insights & Analytics Lead | $130 200–$223 200 | Cambridge, MA | 14. 2. 2024 | 26. 6. 2025 | Certifikované | 498 |
| Platform Architect | $140 500–$180 000 | Lexington, MA | 18. 1. 2024 | 4. 6. 2025 | Certifikované | 503 |
| Associate Director - Strategic Procurement Manager | $143 500–$246 000 | Cambridge, MA | 16. 1. 2024 | 4. 6. 2025 | Certifikované | 505 |
| Manager, GI Rare Data Analytics | $140 500–$180 000 | Lexington, MA | 1. 1. 2024 | 4. 6. 2025 | Certifikované | 520 |
| Director, Strategy and Operations Lead - Omni-channel Engage | $165 200–$283 200 | Cambridge, MA | 18. 10. 2023 | 20. 12. 2024 | Stiahnuté | — |
| Global Health Economics Lead | $165 200–$283 200 | Cambridge, MA | 10. 8. 2023 | 3. 12. 2024 | Certifikované, expirované | 481 |
| Business Domain Technical Architect | $121 000–$180 000 | Bannockburn, IL | 2. 4. 2024 | 19. 11. 2024 | Stiahnuté | — |
| Senior Analyst, Decision & Predictive Analytics | $81 900–$140 400 | Cambridge, MA | 14. 7. 2023 | 4. 11. 2024 | Certifikované, expirované | 479 |
| Product Manager - Knowledge Graph and Advanced Analytics | $136 200–$251 100 | Cambridge, MA | 13. 7. 2023 | 3. 10. 2024 | Certifikované, expirované | 448 |
| IT Business Strategy & Process Lead - Mgr | $156 200–$223 200 | Cambridge, MA | 11. 7. 2023 | 30. 9. 2024 | Certifikované | 447 |
| Global New Product Lead, Neuroscience | $202 100–$339 600 | Cambridge, MA | 10. 6. 2024 | 26. 9. 2024 | Stiahnuté | — |
| Senior IS/IT Analyst, Product Manager – Vaccines Discovery a | $105 000–$180 000 | Cambridge, MA | 24. 7. 2023 | 25. 9. 2024 | Certifikované | 429 |
| Associate Scientific Director | $208 000–$246 000 | Lexington, MA | 22. 9. 2023 | 2. 1. 2024 | Stiahnuté | — |
Platy predstavujú nižšiu hranicu mzdy ponúknutej v každej žiadosti, prepočítané na ročnú sumu; štatistiky využívajú certifikované žiadosti o plný úväzok. Certifikácia PERM je jedným z krokov k zelenej karte; o petícii rozhoduje USCIS. Nie je to právne poradenstvo. Zdroj: Ministerstvo práce USA, údaje o zverejnení PERM OFLC, fiškálne roky 2024–2026 (najnovšie rozhodnutie 30. 6. 2026).